Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
C. Jan Willem Borleffs(Haga Hospital), Martin J. Schalij(Leiden University Medical Center), Jeroen J. Bax(Leiden University), Rutger J. van Bommel(Leiden University Medical Center), Ernst E. van der Wall(Leiden University Medical Center), Enno T. van der Velde(Leiden University Medical Center), Lieselot van Erven(Leiden University Medical Center), Frits R. Rosendaal(Leiden University Medical Center)
Cited by 106
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k